| 20.66 Data as of May 17 |  +0.50 / +2.48%Today’s Change | 7.56 Today|||52-Week Range 23.03 | +97.89% Year-to-Date |
| Sanofi/REGN Commence Enrollment - Analyst Blog May 15 / Zacks.com | Isis Initiates ISIS-STAT3 Study - Analyst Blog May 07 / Zacks.com |
| Isis Gets $3.5M Milestone Payment - Analyst Blog May 14 / Zacks.com | Positive Opinion on Allergan Candidate - Analyst Blog May 06 / Zacks.com |
| Celgene Attains 52-Week High - Analyst Blog May 14 / Zacks.com | Acorda Incurs Loss, Maintains Guidance - Analyst Blog May 06 / Zacks.com |
| Isis Reports In-Line Loss - Analyst Blog May 08 / Zacks.com |
| Previous close | 20.16 |
| Today’s open | 20.30 |
| Day’s range | 20.07 - 20.75 |
| Volume | 1,729,851 |
| Average volume (3 months) | 1,619,117 |
| Market cap | $2.3B |
| Dividend yield | -- |
| Earnings growth (last year) | +23.53% |
| Earnings growth (this year) | -17.26% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +2.99% |
| P/E ratio | NM |
| Price/Sales | 10.29 |
| Price/Book | 11.47 |
| Today’s change | Today’s % change | |
|---|---|---|
| CRLCharles River Labora... | -0.12 | -0.27% |
| ICLRICON PLC | +0.47 | +1.43% |
| PRXLPAREXEL Internationa... | -0.12 | -0.26% |
| ABCOAdvisory Board Co | +0.85 | +1.73% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $102.0M |
| Annual profit (last year) | -$65.5M |
| Net profit margin | -64.16% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Stanley T. Crooke, MD, PhD |
Chief Operating Officer, Secretary & Director B. Lynne Parshall |
Corporate headquarters Carlsbad, California |
.
